Session 4 – Clinical Lipidomics – Current Applications
High through put plasma lipidomics: Development and translation of metabolic and cardiovascular risk scores
Professor Peter Meikle is Head of the Systems Biology Domain, Co-Lead of the Obesity and Lipids Program and Head of the Metabolomics Laboratory at the Baker Heart and Diabetes Institute.
He is co-Director of the Australian Cardiovascular Alliance, Precision Medicine Flagship and was recently appointed Head of the Baker Department of Cardiovascular Research, Translation and Implementation at La Trobe University.
His research has a focus on the dysregulation of lipid metabolism associated with metabolic diseases including obesity, diabetes, cardiovascular and Alzheimer’s disease, and its relationship to the pathogenesis of these disease states.
This work is leading to new approaches to early diagnosis and risk assessment, and to the development of new lipid modulating therapies for chronic disease.